OlympiA Trial

09 Oct 2015 by Krystal Barter

Female doctor constulting with senior patient in small clinic.

I’m the kind of person who likes to be proactive. If I can do something that helps others and helps researchers, by participating in a clinical trial, then I think that’s a positive thing to do. I’m turning my experience into a positive and by participating in the OlympiA clinical trial, I’m doing something worthwhile so that hopefully there will be treatments available for others. – Iris

OlympiA is an international study which will enrol 1500 patients in 23 countries. It is open to women and men diagnosed with HER-2 negative breast cancer provided they have an inherited BRCA1 or BRCA2 gene mutation. The OlympiA clinical study is investigating whether taking olaparib tablets twice a day for 12 months can increase the chance of remaining free from breast cancer recurrence which may result in a new standard treatment.

More information about the study is available at www.anzbctg.org. Women and men with HER-2 negative breast cancer diagnosed in the past year and who are interested in participating in the OlympiA clinical trial should speak to their cancer specialist.


Follow Us

Latest Posts


This error message is only visible to WordPress admins

Error: API requests are being delayed for this account. New posts will not be retrieved.

Log in as an administrator and view the Instagram Feed settings page for more details.